Find blood cell counter for hospitals clinics and labs
Source 30 blood cell counter models from verified Chinese manufacturers. Buyers can compare specifications like throughput, sample volume, and calibration modes to select the right automated hematology analyzer for clinical diagnostics.
Key considerations
Products List
Comprehensive Sourcing Guide
Strategic Sourcing Guide for Blood Cell Counter Equipment
The global demand for automated hematology analysis has driven a significant expansion in the market for blood cell counters, particularly within the Chinese manufacturing sector. For procurement professionals and medical facility administrators, navigating this landscape requires a disciplined approach that distinguishes between verified product attributes and general market expectations. The core keyword "blood cell counter" encompasses a diverse range of devices, from portable units designed for point-of-care testing to high-throughput systems suitable for central laboratories. This guide synthesizes observed market data and technical specifications to provide a robust framework for sourcing decisions, ensuring that buyers can identify equipment that aligns with their specific operational needs while maintaining strict adherence to safety and quality standards.
Technical Architecture and Performance Metrics
Understanding the technical architecture of a blood cell counter is the first step in effective sourcing. The devices observed in the current market operate on established principles, primarily utilizing the principle of blood cell counting to deliver full blood count results. A critical performance metric for any hematology analyzer is throughput, which dictates the volume of samples the system can process within a given timeframe. In the observed product range, specific models demonstrate a throughput capability of 35 samples per hour. This figure is a vital benchmark for facilities estimating their daily workload and determining if the equipment can handle peak demand without creating bottlenecks.
Differentiation capabilities are another essential technical consideration. The market features systems offering 3-part differentiation, which allows for the separation of white blood cell populations into specific categories. This level of analysis is fundamental for diagnosing a wide array of hematological conditions. Furthermore, the calibration modes available on these units often include both auto and manual options. This flexibility is crucial for laboratories that require precise control over their testing parameters or need to adapt to varying sample types. The sample volume required for these operations is typically minimal, with observed specifications indicating a requirement of 9.8 microliters for peripheral or venous blood. This low volume requirement is particularly beneficial for pediatric and neonatal applications, where blood collection is a limiting factor.
The physical dimensions and power requirements of the equipment also play a significant role in facility planning. Units vary in size, with external dimensions observed at approximately 22016678 mm, suggesting a compact footprint suitable for smaller clinics or mobile units. Power consumption is generally low, with ratings around 5W, and the systems are designed to operate on standard voltage inputs of 220V±10% at 50Hz. These specifications ensure compatibility with a wide range of electrical infrastructures globally. Additionally, the counting capacity per group often ranges from 0 to 99, allowing for substantial data storage within the device's memory before requiring a download or transfer.
Compliance, Certification, and Regulatory Standards
In the medical device sector, compliance is not merely a formality but a prerequisite for market entry and operational safety. When sourcing blood cell counters, buyers must verify that the equipment meets international and regional regulatory standards. The most frequently observed certification in the current product listings is the CE mark, indicating conformity with health, safety, and environmental protection standards for products sold within the European Economic Area. This certification is a strong indicator that the manufacturer has undergone rigorous testing and quality assurance processes.
Beyond the CE mark, other certifications such as ISO13485 are critical for manufacturers of medical equipment. This standard specifically addresses quality management systems for medical devices, ensuring that the production processes are consistent and capable of delivering safe products. Some listings also reference classifications related to the physiological functions of diagnosis and monitoring equipment, which helps categorize the device within broader regulatory frameworks. Buyers should be aware that while certifications like CE and ISO13485 are present in the supply chain, the specific scope of these certifications for any given model must be verified against the manufacturer's documentation.
The origin of the product is another factor closely tied to compliance. The majority of the observed blood cell counters originate from China, with specific manufacturing hubs identified in Guangzhou and the broader Guangdong region. These regions have developed robust ecosystems for medical device production, often adhering to international standards to facilitate export. However, the "Made in China" label does not guarantee uniform quality; therefore, the presence of specific certifications on the product listing is the primary verification tool for buyers. It is essential to confirm that the certification applies to the specific model number, such as the KT6200 or MCL-HA001, rather than being a generic claim for the entire brand.
Cost Drivers and Procurement Economics
The pricing landscape for blood cell counters is characterized by a wide variance, reflecting differences in technology, throughput, and feature sets. The observed price range in the market spans from 6 USD to 6750 USD. This broad spectrum suggests that the market includes both highly basic, potentially single-use or entry-level diagnostic tools and sophisticated, fully automated laboratory systems. The lower end of the price range may correspond to simpler devices or accessories, while the higher end likely represents comprehensive systems with advanced differentiation capabilities and higher throughput.
When evaluating cost, buyers must look beyond the initial purchase price to consider the total cost of ownership. This includes the cost of reagents, maintenance, and potential calibration services. Some products are listed with specific reagent technologies, such as "Clot Clear: High Voltage Burn," which may influence the ongoing operational costs. The selling units are typically listed as single items, implying that the price quoted is for the complete system rather than a bulk order. However, the Minimum Order Quantity (MOQ) observed is consistently 1, which offers flexibility for buyers who need to procure a single unit for a specific department or pilot program.
Customization is another factor that can influence cost. Many suppliers offer customization options, allowing buyers to tailor the device to specific workflow requirements or branding needs. While this adds value, it may also extend the lead time and increase the unit price. The packing standards, described as "Standard Packing for Export" or "Export Standard Packaging for Air and Sea," are designed to ensure the equipment arrives in pristine condition, which is a cost-saving measure in itself by reducing the risk of damage during transit. Buyers should verify if these packing standards include specific insurance or handling requirements that might affect the final landed cost.
Typical Applications and Operational Context
Blood cell counters serve a variety of clinical settings, ranging from large hospital laboratories to small clinics and mobile health units. The versatility of these devices is evident in their ability to handle samples from diverse patient demographics, including newborns, children, males, and females. The "Universal" classification of some models indicates their adaptability to different patient populations without requiring significant hardware changes. This is particularly important for facilities that serve a mixed demographic or operate in regions with varying patient profiles.
The principle of operation, often described as "Full Blood Count Machine" or "Auto Hematology," makes these devices suitable for routine screening and diagnostic testing. The automated nature of the counters reduces the risk of human error and increases the speed of diagnosis. In settings where rapid results are critical, such as emergency departments or intensive care units, the throughput of 35 samples per hour provides a significant advantage. Furthermore, the inclusion of discriminator functions, such as "Float and Fix Discriminator," enhances the accuracy of the results by distinguishing between different cell types and potential interferences.
The portability of some units, described as "Portable Hematology," expands their application to field testing and remote locations. These devices are ideal for situations where a full laboratory setup is not feasible, allowing for on-site analysis of blood samples. The compact dimensions and low power consumption of these portable units make them easy to transport and deploy in various environments. Whether used in a central laboratory or a remote clinic, the ability to perform automated white blood cell counting and full blood counts is a fundamental requirement for modern medical diagnostics.
Supplier Evaluation and Quality Assurance
Evaluating suppliers in the blood cell counter market requires a focus on reliability, after-sales support, and adherence to quality standards. The observed market includes suppliers offering online technical support, which is a critical component of long-term operational success. When a device encounters a technical issue or requires calibration, the availability of remote assistance can minimize downtime and ensure continuous service. The warranty period, typically observed as 1 year, is another key metric for assessing supplier confidence in their products.
Quality control processes should be a primary consideration during supplier selection. Buyers should verify that the manufacturer adheres to recognized quality management systems, such as ISO13485, and that the products undergo rigorous testing before shipment. The classification of the device as a "Biochemical Apparatus" or "Medical Equipment" implies a level of scrutiny that should be reflected in the supplier's documentation. Additionally, the specific model numbers, such as MCL-KT-6200 or MCT-DH01, should be cross-referenced with the supplier's product catalog to ensure consistency and authenticity.
The "Brand Name" associated with the products, such as "KT," serves as an identifier for the manufacturer, but buyers should not rely solely on brand recognition. Instead, they should investigate the manufacturer's track record, the specific certifications held by the facility, and the availability of spare parts. The "Standard Package" and "Export Standard Packaging" mentioned in product listings are indicators of the supplier's attention to detail in logistics, which is essential for maintaining the integrity of sensitive medical equipment during international shipping.
Long-Term Procurement and Lifecycle Management
Sourcing a blood cell counter is not a one-time transaction but the beginning of a long-term relationship with the supplier. Buyers must consider the lifecycle of the equipment, including maintenance schedules, reagent availability, and potential upgrades. The "After-Sale Service" component, specifically online technical support, is a vital element of this lifecycle management. It ensures that the facility can resolve issues quickly without waiting for on-site visits, which can be costly and time-consuming.
The customization options available, such as specific reagent technologies or interface configurations, should be evaluated for their long-term viability. As medical standards evolve, the ability to adapt the device to new requirements will be crucial. The "Calibration Mode" flexibility, offering both auto and manual options, provides a foundation for adapting to changing laboratory protocols. Furthermore, the "Count Capacity" of 0-99 per group suggests that the device has sufficient memory for routine operations, but buyers should verify if this capacity can be expanded or if data export capabilities are available for integration with laboratory information systems.
Finally, the "Standard Size" and "Export Standard Packaging" observed in the market indicate a commitment to global logistics standards. This ensures that the equipment can be easily transported and installed in various locations. Buyers should plan for the eventual replacement or upgrade of the equipment, considering the availability of newer models and the compatibility of existing reagents and accessories. By focusing on these long-term factors, procurement professionals can ensure that their investment in blood cell counter technology remains valuable and effective for years to come.
FAQs
What is the throughput of the observed blood cell counter models?
The observed blood cell counter models demonstrate a throughput capability of 35 samples per hour. This performance metric is critical for facilities estimating their daily workload and determining if the equipment can handle peak demand without creating bottlenecks in the laboratory workflow.
Which certifications are commonly found on these blood cell counter devices?
The most frequently observed certification is the CE mark, indicating conformity with European health and safety standards. Some listings also reference ISO13485, which addresses quality management systems for medical devices to ensure consistent and safe production processes.
How much sample volume is required for the blood cell counter operation?
The required sample volume is typically minimal, with observed specifications indicating a need for 9.8 microliters of peripheral or venous blood. This low volume requirement is particularly beneficial for pediatric and neonatal applications where blood collection is a limiting factor.
What is the price range for the blood cell counter equipment in the market?
The observed price range spans from 6 USD to 6750 USD, reflecting differences in technology and feature sets. The lower end may correspond to simpler devices while the higher end likely represents comprehensive systems with advanced differentiation capabilities and higher throughput.
Can the blood cell counter be customized for specific workflow requirements?
Yes, many suppliers offer customization options allowing buyers to tailor the device to specific workflow requirements or branding needs. While this adds value, it may also extend the lead time and increase the unit price compared to standard configurations.
Where are the blood cell counter manufacturing locations primarily situated?
The majority of the observed blood cell counters originate from China, with specific manufacturing hubs identified in Guangzhou and the broader Guangdong region. These regions have developed robust ecosystems for medical device production often adhering to international standards for export.